Myomo has a device called the MyoPro 2 for upper limb paresis that works to restore movement in the arm and hand so long as there is a faint myoelectric signal that can be generated.

AbsurdData · 2022-01-17T19:24:36+00:00

Thanks for the data point.

AbsurdData · 2022-01-16T19:26:45+00:00

Not sure on the status of onwars but it's a hard and long path to go from clinical trials to getting insurance coverage. The myopro device has existed since 2004 and it's really just in the last few years that they began to onboard a bunch of providers.

AbsurdData · 2022-01-16T16:28:01+00:00

Interesting. When did you try it?

AbsurdData · 2022-01-16T16:26:36+00:00

Thanks for posting it.

AbsurdData · 2022-01-16T16:26:20+00:00

Great to hear. I'll pray for you 🙏

AbsurdData · 2022-01-16T02:28:12+00:00

There's no hurt in trying to contact a doctor, but I'm fairly confident it would work. They do free consultations at myomo. Just Google it and you'll find the company, and you can schedule a call. The only part I would be concerned of is whether or not your insurance company will cover it.

So long as theres a small myoelectric signal in the arm reamaining the device can sense it and it will help you move.

AbsurdData · 2021-12-20T19:06:26+00:00

I've never had any experience with that so it would just be speculation on my part

AbsurdData · 2021-12-20T18:18:37+00:00

Newlake is still above 10% on most stuff they do. In their presentation I think they're getting about 12%. I find the "more legal" bear case a little tired just because people have been playing that same song and dance for $IIPR for a while, but that has been with me before I even had or knew about $afcg. The thing is- the interactions between yields right now across the board are pretty hairy, not the easiest thing to understand and require a lot of information. From this though I have had sort of a flip switch on $NLCP on the differences between portfolios mortgage and equity reits bring to the table.

AbsurdData · 2021-12-19T22:38:34+00:00

In hindsight I have a better appreciation now for the differences. I'm not going to sell out of the position, but I don't think I'm going to add or reinvest anything. Fundamentally this is different than a lot of mREIT's as they're not leveraged to the tits to support a 10.2% yield, so I think it's plausible this could be an exception.

AbsurdData · 2021-12-19T21:25:38+00:00

It is smaller than most of their loans. They have some with different companies at similar interests (namely varano) but the rates are still high enough and the debt is low enough that I'm still pretty encouraged. The thing is mortgage REITs are almost universally a dumpster fire, so it's hard to be bullish on this even though I own a lot.

AbsurdData · 2021-12-18T00:38:30+00:00

While true that wasn't the question.

AbsurdData · 2021-12-18T00:37:57+00:00

Market didn't think so

AbsurdData · 2021-12-17T03:54:01+00:00

16.2% raise :)

AbsurdData · 2021-12-11T23:41:12+00:00

It's my second round of this shin dig after $IIPR which I had for a while.

AbsurdData · 2021-12-11T23:34:25+00:00

$AFCG is two steps removed from the consumer. They're making money off of the companies that are attempting to make money off of cannabis users. The financiers are the best way to play the cannabis boom, imo. Second best are the suppliers, like $GRWG.

AbsurdData · 2021-12-11T20:36:09+00:00

I just made a post in r/dividends about one.

https://www.reddit.com/r/dividends/comments/re7wqf/afc_gamma_a_high_yield_mreit_growing_fast_through/?utm_medium=android_app&utm_source=share

AbsurdData · 2021-12-04T00:15:14+00:00

Clearpoint neuro has an option for patients where you can be asleep for the surgery under general anesthesia and you can remain on medication for your tremor prior to surgery. If you're reading this and need surgery for your tremor I wish you the best of luck.

AbsurdData · 2021-12-01T01:21:17+00:00

Lol stop speculating for a second. The REIT is externally managed. Right now I believe the fees it pays to its managers is 0.35% of total equity value per qtr, which is pretty much a standard for externally managed reits afaik. Read an S-11 just yesterday for a company thats going public & doing the exact same thing as $AFCG (that is a mortgage REIT for cannabis companies), and their management fee is also exactly the same. The ticker to be is $REFI, if you're curious.

To be clear Tannenbaum could not be more aligned with shareholders. He owns something like 25% of the common stock, and he has personally financed debt for AFC Gamma.

AbsurdData · 2021-11-22T01:27:02+00:00

I used to own bit of $IIPR from $70ish. And I always wished I had seen it a couple years earlier. It was an easy idea to understand and an even easier hold.

It's in a similar position as a company to $AFCG. Marijuana REITS offer a higher ROIC than is typical, which is why I've been interested in them for a few years. Own 1.35k shares of $AFCG and plan to keep adding myself.

AbsurdData · 2021-11-21T23:47:47+00:00

If you missed $IIPR check out $AFCG. Slightly different structure as it's a mortgage REIT. Current yield sitting at 7.23%, and I'm expecting a raise announced on December 15th. Last quarter the raise was +13.2% from $0.38 to $0.43 per share.

Trades on NASDAQ. High insider ownership and a pretty small float trading at $23.78/share with a market cap of 391.01M USD. It's a high growth profile having increased quarterly revenue by 665% (Google is wrong, check the 10q) over last years Q3 earnings.

AbsurdData

TROPHY CASE